Cargando…
Does external reference pricing deliver what it promises? Evidence on its impact at national level
BACKGROUND: External reference pricing (ERP) is widely used to regulate pharmaceutical prices and help determine reimbursement. Its implementation varies substantially across countries, making it difficult to study and understand its impact on key policy objectives. OBJECTIVES: To assess the evidenc...
Autores principales: | Kanavos, Panos, Fontrier, Anna-Maria, Gill, Jennifer, Efthymiadou, Olina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058621/ https://www.ncbi.nlm.nih.gov/pubmed/31583483 http://dx.doi.org/10.1007/s10198-019-01116-4 |
Ejemplares similares
-
Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
por: Efthymiadou, Olina, et al.
Publicado: (2022) -
Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries
por: Fontrier, Anna-Maria, et al.
Publicado: (2021) -
Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries
por: Fontrier, Anna-Maria, et al.
Publicado: (2022) -
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
por: Efthymiadou, Olina
Publicado: (2022) -
How does external reference pricing work in developing countries: evidence from Iran
por: Babaie, Fatemeh, et al.
Publicado: (2023)